Yale Pathology Legacy Tissue Donation: The Physician Perspective
December 07, 2022Information
Harry Sanchez, MD, Director of the Yale Pathology Legacy Tissue Donation Program, and Marcello DiStasio, MD, PhD, Co-Director, discuss the importance of tissue donation to cancer research.
ID9238
To CiteDCA Citation Guide
- 00:04My name's Harry Sanchez.
- 00:05I'm the director of the autopsy service,
- 00:08and along with Marcello Destasio,
- 00:10I'm the Co director of the
- 00:13Yale legacy Tissue Donation
- 00:15program. Very much like
- 00:16organ donation programs,
- 00:17people who become part of the
- 00:20legacy tissue donation program help
- 00:22address a pressing medical need.
- 00:24By donating their tissue
- 00:26after they pass away,
- 00:27donors are providing cancer
- 00:29researchers with invaluable
- 00:30tissue that can't be obtained.
- 00:32Any other
- 00:33way, at any price.
- 00:35Clinical scientists have
- 00:36many avenues for research,
- 00:38including animal models,
- 00:39cell culture, surgical specimens
- 00:40and standard autopsies.
- 00:42But each of these has a limitation.
- 00:45Tissues that patients donations
- 00:46provide represent an invaluable
- 00:48resource for us to understand
- 00:50the exact mechanisms by which
- 00:52diseases start and progress.
- 00:54This program is
- 00:55patient driven and completely reliant on
- 00:58the incredible generosity of our donors,
- 01:00a remarkable act of altruism.
- 01:02As the power to advance our understanding
- 01:04of cancer biology and the potential to
- 01:06change the way we treat cancer, there's
- 01:08no way we can thank you enough.